Clinical characteristics of control and hypertensive women with and without gallstones
| Controls | Hypertensives | ||||
|---|---|---|---|---|---|
| GSD | No GSD | GSD | No GSD | ||
| Number of subjects | 47 | 220 | 54 | 203 | |
| Age (range) (years) | 54 (52–55) | 51 (51–52) | 53 (51–54) | 52 (51–52) | |
| BMI (kg/m2) | 28 (26–30) | 26 (25–26) | 30 (28–32) | 28 (28–29) | |
| Fb glucose (mmol/l) | 4.51-150 (4.3–4.8) | 4.3 (4.2–4.4) | 5.61-151 (4.9–6.4) | 4.5 (4.3–4.77) | |
| fS insulin (mU/l) | 12.21-150 (10.0–14-4) | 9.1 (8.3–9.9) | 17.81-151 (14.1–21.5) | 12.8 (11.5–14.0) | |
| Two hour glucose (mmol/l) | 6.01-150 (5.4–6.8) | 5.3 (5.0–5.5) | 8.41-151(6.7–9.9) | 6.2 (5.9–6.6) | |
| Two hour insulin (mmol/l) | 77.91-150(55.1–101) | 53.4 (4.81–58.7) | 112.61-151 (71.8–153) | 80.0 (75.9–96.1) | |
| Plasma cholesterol (mmol/l) | 5.7 (5.4–6.1) | 5.5 (5.4–5.6) | 5.7 (5.3–6.1) | 5.7 (5.6–5.8) | |
| LDL cholesterol (mmol/l) | 3.4 (3.1–3.7) | 3.3 (3.2–3.4) | 3.4 (3.1–3.7) | 3.5 (3.4–3.6) | |
| HDL cholesterol (mmol/l) | 1.5 (1.4–1.6) | 1.6 (1.5–1.7) | 1.3 (1.2–1.4) | 1.5 (1.4–1.6) | |
| Triglycerides (mmol/l) | 1.51-150 (1.2–1.9) | 1.1 (1.0–1.2) | 2.01-151 (1.5–2.5) | 1.5 (1.4–1.6) | |